ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,273,000 | -49.1% | 37,839 | -28.5% | 0.05% | -49.5% |
| Q2 2019 | $4,467,000 | +46.9% | 52,939 | +66.3% | 0.10% | +65.6% |
| Q1 2019 | $3,041,000 | +25.3% | 31,843 | -7.1% | 0.06% | +17.3% |
| Q4 2018 | $2,427,000 | +35.0% | 34,277 | +62.9% | 0.05% | +62.5% |
| Q3 2018 | $1,798,000 | -28.4% | 21,042 | -2.9% | 0.03% | -25.6% |
| Q2 2018 | $2,510,000 | +184.6% | 21,661 | +98.7% | 0.04% | +186.7% |
| Q1 2018 | $882,000 | -1.1% | 10,900 | -28.3% | 0.02% | 0.0% |
| Q4 2017 | $892,000 | +41.4% | 15,200 | +12.6% | 0.02% | 0.0% |
| Q3 2017 | $631,000 | +30.9% | 13,500 | +0.7% | 0.02% | +25.0% |
| Q2 2017 | $482,000 | +16.7% | 13,400 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $413,000 | -7.4% | 13,400 | +0.8% | 0.01% | -16.7% |
| Q4 2016 | $446,000 | – | 13,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |